Laurent Beaugerie
#145,324
Most Influential Person Now
Laurent Beaugerie's AcademicInfluence.com Rankings
Laurent Beaugeriemedical Degrees
Medical
#2727
World Rank
#3159
Historical Rank
Gastroenterology
#56
World Rank
#58
Historical Rank
Download Badge
Medical
Why Is Laurent Beaugerie Influential?
(Suggest an Edit or Addition)Laurent Beaugerie's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. (2006) (1424)
- High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. (2004) (1410)
- Long-Term Evolution of Disease Behavior of Crohn's Disease (2002) (1224)
- Low counts of Faecalibacterium prausnitzii in colitis microbiota (2009) (1120)
- Mapping of a susceptibility locus for Crohn's disease on chromosome 16 (1996) (1046)
- Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study (2009) (822)
- CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands (2016) (817)
- Fungal microbiota dysbiosis in IBD (2016) (756)
- Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery (2005) (667)
- Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases (2012) (558)
- Cancers complicating inflammatory bowel disease. (2015) (490)
- Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. (2013) (477)
- Predictors of Crohn's disease. (2006) (475)
- Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. (2011) (450)
- Smoking cessation and the course of Crohn's disease: an intervention study. (2001) (432)
- A structural variation reference for medical and population genetics (2020) (394)
- Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis. (2015) (316)
- European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies. (2015) (315)
- Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease. (2012) (310)
- Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. (2013) (298)
- Review article: drug‐induced microscopic colitis – proposal for a scoring system and review of the literature (2005) (246)
- Natural history of Crohn's disease: Comparison between childhood‐ and adult‐onset disease (2010) (241)
- Effects of cigarette smoking on the long-term course of Crohn's disease. (1996) (233)
- The role of anatomic factors in nutritional autonomy after extensive small bowel resection. (1996) (232)
- Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial (2018) (214)
- Crohn's disease clinical course and severity in obese patients. (2002) (206)
- Impact of cessation of smoking on the course of ulcerative colitis (2001) (201)
- Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy (2010) (184)
- Antibiotic-associated diarrhoea (2004) (180)
- Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study (2009) (165)
- Small Bowel Adenocarcinoma in Patients with Crohn's Disease Compared with Small Bowel Adenocarcinoma De Novo (2005) (159)
- Effects of cigarette smoking on the long-term course of Crohn's disease (1996) (159)
- Significance of Erythema Nodosum and Pyoderma Gangrenosum in Inflammatory Bowel Diseases: A Cohort Study of 2402 Patients (2008) (156)
- Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study (2020) (149)
- Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study (2020) (149)
- Saccharomyces boulardii does not prevent relapse of Crohn's disease. (2013) (143)
- Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III). (2014) (138)
- Effects of appendicectomy on the course of ulcerative colitis (2002) (137)
- Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer (2013) (119)
- Symptomatic response to varying levels of fructo-oligosaccharides consumed occasionally or regularly. (1995) (114)
- Antibiotic‐associated diarrhoea and Clostridium difficile> in the community (2003) (109)
- Factors affecting outcomes in Crohn's disease over 15 years (2012) (108)
- Drug induced lymphocytic colitis. (1994) (108)
- Predictive Factors of Response to Cyclosporine in Steroid-Refractory Ulcerative Colitis (2008) (108)
- Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum. (2005) (106)
- Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study (2016) (106)
- Effect of Antibiotic Therapy on Human Fecal Microbiota and the Relation to the Development of Clostridium difficile (2008) (104)
- Cancer risk in immune-mediated inflammatory diseases (IMID) (2013) (104)
- Patient-reported Outcomes in a French Nationwide Survey of Inflammatory Bowel Disease Patients (2017) (104)
- Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease (2019) (95)
- Gender differences in the response of colitis to smoking. (2004) (94)
- Effects of light smoking consumption on the clinical course of Crohn's disease (2009) (93)
- Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease (2012) (93)
- Development of the Paris Definition of Early Crohn's Disease for Disease-Modification Trials: Results of an International Expert Opinion Process (2012) (92)
- Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis. (2008) (91)
- Oral contraceptive use and the clinical course of Crohn’s disease: a prospective cohort study (1999) (90)
- Transcript expression-aware annotation improves rare variant interpretation (2020) (89)
- Clinical, serological and genetic predictors of inflammatory bowel disease course. (2012) (88)
- Risk Factors for Neoplasia in Inflammatory Bowel Disease Patients With Pancolitis (2010) (88)
- Bacterial protein signals are associated with Crohn’s disease (2014) (88)
- Klebsiella oxytoca as an agent of antibiotic-associated hemorrhagic colitis. (2003) (88)
- Gastrointestinal involvement and manifestations in systemic mastocytosis (2010) (87)
- Increased risk of acute myeloid leukemias and myelodysplastic syndromes in patients who received thiopurine treatment for inflammatory bowel disease. (2014) (87)
- Evaluating drug targets through human loss-of-function genetic variation (2019) (86)
- Ranitidine, diarrhoea, and lymphocytic colitis. (1995) (83)
- Detection of Dysplasia or Cancer in 3.5% of Patients With Inflammatory Bowel Disease and Colonic Strictures. (2015) (82)
- Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study (2017) (82)
- Inflammatory bowel disease therapies and cancer risk: where are we and where are we going? (2011) (78)
- Characterising the loss-of-function impact of 5’ untranslated region variants in 15,708 individuals (2019) (78)
- Crohn’s disease severity in familial and sporadic cases (1999) (78)
- Increased incidence of systemic serious viral infections in patients with inflammatory bowel disease associates with active disease and use of thiopurines (2020) (78)
- Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability. (2007) (77)
- Risk Factors Associated With Small Bowel Adenocarcinoma in Crohn's Disease: A Case–Control Study (2008) (77)
- Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprine (2009) (76)
- Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle (2009) (75)
- Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria (2019) (75)
- Thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel disease: a meta-analysis. (2014) (72)
- Epstein-Barr Virus Viral Load in Crohn’s Disease: Effect of Immunosuppressive Therapy (2004) (71)
- Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea. (2004) (71)
- Impact of pregnancy on the clinical activity of Crohn's disease (2005) (71)
- The effect of LRRK2 loss-of-function variants in humans (2020) (69)
- High Risk of Anal and Rectal Cancer in Patients With Anal and/or Perianal Crohn’s Disease (2017) (68)
- Gastrointestinal manifestations in mastocytosis: a study of 83 patients. (2013) (66)
- Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine (2011) (65)
- Diagnosis, and prognosis of AIDS‐related cholangitis (1995) (65)
- The effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti‐tumour necrosis factor (2020) (65)
- [Effect of smoking on the long-term course of ulcerative colitis]. (1998) (65)
- Long-term outcome of patients with Crohn's disease who respond to azathioprine. (2013) (65)
- Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population (2016) (64)
- Small Bowel Adenocarcinomas Complicating Crohn's Disease Are Associated With Dysplasia: A Pathological and Molecular Study (2014) (64)
- Digestion and absorption in the human intestine of three sugar alcohols. (1990) (63)
- The clinicopathological features of extensive small intestinal CD4 T cell infiltration (1999) (62)
- Incidence, Presentation, and Prognosis of Small Bowel Adenocarcinoma in Patients with Small Bowel Crohn's Disease: A Prospective Observational Study (2013) (62)
- Specificities of the intestinal microbiota in patients with inflammatory bowel disease and Clostridium difficile infection (2018) (62)
- The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease (2014) (61)
- Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases (2017) (60)
- Colorectal neoplasia in Crohn's colitis: a retrospective comparative study with ulcerative colitis (2007) (60)
- Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort (2011) (57)
- Faecal microbiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of Faecal microbiota Transplantation. (2016) (57)
- Predicting, Preventing, and Managing Treatment-related Complications in Patients With Inflammatory Bowel Diseases. (2020) (56)
- Clostridium difficile infection in acute flares of inflammatory bowel disease: A prospective study. (2017) (56)
- Effect of indinavir on HIV‐related wasting (1998) (55)
- Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives (2018) (55)
- Definition and diagnosis of cytomegalovirus colitis in patients infected by human immunodeficiency virus. (1997) (55)
- Cholangiopathy associated with Microsporidia infection of the common bile duct mucosa in a patient with HIV infection. (1992) (54)
- Etiology and management of toxic megacolon in patients with human immunodeficiency virus infection. (1994) (54)
- Overexpression of microRNAs-155 and 21 targeting mismatch repair proteins in inflammatory bowel diseases. (2013) (54)
- The management of immunosuppression in patients with inflammatory bowel disease and cancer (2013) (50)
- Improvement in protein absorption with a small-peptide-based diet in patients with high jejunostomy. (1992) (49)
- Non-steroidal anti-inflammatory drugs as a risk factor for acute diarrhoea: a case crossover study (2003) (49)
- Current smoking differentially affects blood mononuclear cells from patients with crohn's disease and ulcerative colitis: Relevance to its adverse role in the disease (2012) (48)
- Lymphoma: the bête noire of the long-term use of thiopurines in adult and elderly patients with inflammatory bowel disease. (2013) (47)
- Adaptive hyperphagia in patients with postsurgical malabsorption. (1990) (46)
- Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases (2018) (46)
- Predictive Factors of Response of Perianal Crohn’s Disease to Azathioprine or 6-Mercaptopurine (2003) (45)
- Colorectal cancer prevention in patients with ulcerative colitis. (2018) (45)
- Functional adaptation after extensive small bowel resection in humans (1994) (44)
- Erythema nodosum-like eruption as a manifestation of azathioprine hypersensitivity in patients with inflammatory bowel disease. (2007) (44)
- Genotype/Phenotype Analyses for 53 Crohn’s Disease Associated Genetic Polymorphisms (2012) (43)
- Changes in the Lémann Index Values During the First Years of Crohn's Disease. (2015) (43)
- Modulation of orocaecal transit time by hypnosis. (1991) (42)
- Comparative value of colonic biopsy and intraluminal fluid culture for diagnosis of bacterial acute colitis in immunocompetent patients. Infectious Colitis Study Group. (1999) (41)
- Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. G.E.T.A.I.D. (1994) (41)
- 818 Excess Risk of Lymphoproliferative Disorders (LPD) in Inflammatory Bowel Diseases (IBD): Interim Results of the Cesame Cohort (2008) (40)
- Macronutrient intake and malabsorption in HIV infection: a comparison with other malabsorptive states (1997) (40)
- Use of azathioprine in IBD: modern aspects of an old drug (2014) (40)
- Classification of the sequelae of bowel resection for Crohn's disease (1994) (39)
- Prevalence and risk factors of Clostridium difficile infection in patients hospitalized for flare of inflammatory bowel disease: a retrospective assessment. (2014) (39)
- Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study. (2015) (39)
- Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease (2016) (37)
- Risk of Melanoma in Patients Who Receive Thiopurines for Inflammatory Bowel Disease Is Not Increased (2012) (36)
- Balancing Benefit vs Risk of Immunosuppressive Therapy for Individual Patients With Inflammatory Bowel Diseases (2019) (35)
- Effects of an isotonic oral rehydration solution, enriched with glutamine, on fluid and sodium absorption in patients with short‐bowel syndrome (1997) (35)
- Inter-kingdom effect on epithelial cells of the N-Acyl homoserine lactone 3-oxo-C12:2, a major quorum-sensing molecule from gut microbiota (2018) (35)
- Anal Neoplasia in Inflammatory Bowel Disease: Classification Proposal, Epidemiology, Carcinogenesis, and Risk Management Perspectives (2017) (34)
- Prior appendectomy and the phenotype and course of Crohn's disease. (2006) (33)
- Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study (2019) (33)
- Linking strain engraftment in fecal microbiota transplantation with maintenance of remission in Crohn's disease. (2020) (33)
- The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease (2017) (32)
- Factors Associated with Durable Response to Infliximab in Crohn's Disease 5 Years and Beyond: A Multicenter International Cohort (2015) (32)
- Genetic effects on the commensal microbiota in inflammatory bowel disease patients (2019) (30)
- Reversal of abnormal collagen production in Crohn’s disease intestinal biopsies treated with regenerating agents (2003) (30)
- Malignancies in Inflammatory Bowel Disease (2020) (29)
- Towards a personalized benefit-risk balance for immunosuppressive therapy in inflammatory bowel disease (2018) (29)
- Isotonic high-sodium oral rehydration solution for increasing sodium absorption in patients with short-bowel syndrome. (1991) (28)
- Crohn's disease over 20 years after diagnosis in a referral population. (2004) (28)
- Factors of weight loss in patients with HIV and chronic diarrhea. (1998) (28)
- Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study. (1996) (28)
- 281 Thiopurine Therapy Is Associated with a Three-Fold Decrease in the Incidence of Advanced Colorectal Neoplasia in IBD Patients with Longstanding Extensive Colitis: Results from the CESAME Cohort (2009) (27)
- Impact of the diagnosis and treatment of cancer on the course of inflammatory bowel disease. (2014) (26)
- [Sclerosing peritonitis. A series of 10 cases and review of the literature]. (1995) (26)
- Use of Immunosuppressants and Biologicals in Patients with Previous Cancer (2013) (26)
- Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study (2017) (24)
- Postoperative Morbidity Risks Following Ileocolic Resection for Crohn's Disease Treated With Anti-TNF Alpha Therapy: A Retrospective Study of 360 Patients. (2018) (24)
- Noncolorectal Malignancies in Inflammatory Bowel Disease: More than Meets the Eye (2009) (23)
- [Factors associated with hyperhomocysteinemia in Crohn's disease]. (2001) (22)
- Clinical activity is an independent risk factor of ischemic heart and cerebrovascular arterial disease in patients with inflammatory bowel disease (2018) (21)
- Intestinal dysbiosis in inflammatory bowel disease associated with primary immunodeficiency. (2019) (21)
- Immunosuppression-Related Lymphomas and Cancers in IBD: How Can They Be Prevented? (2012) (20)
- Association Between Microscopic Lesions at Ileal Resection Margin and Recurrence After Surgery in Patients With Crohn's Disease. (2019) (20)
- Management of inflammatory bowel disease patients with a cancer history. (2014) (20)
- Crypt abscess-associated microbiota in inflammatory bowel disease and acute self-limited colitis. (2010) (19)
- [Comparison of long-term course of perforating and non-perforating Crohn disease]. (1998) (19)
- Clinicopathological and Molecular Specificities of Inflammatory Bowel Disease–Related Colorectal Neoplastic Lesions: The Role of Inflammation (2018) (19)
- Benefit of infliximab reintroduction after successive failure of infliximab and adalimumab in Crohn's disease. (2015) (19)
- Effects of an isotonic oral rehydration solution, enriched with glutamine, on fluid and sodium absorption in patients with a short-bowel. (1997) (19)
- Risk factors of acute diarrhoea in summer – a nation-wide French case-control study (2000) (19)
- Human Intestinal Microbiota Gene Risk Factors for Antibiotic-Associated Diarrhea: Perspectives for Prevention (2010) (18)
- Ustekinumab treatment for neutrophilic dermatoses associated with Crohn's disease: A multicenter retrospective study (2019) (18)
- [Undiagnosed celiac disease in childhood]. (2002) (18)
- [Morbid associations in Crohn's disease. Study of a series of 832 patients]. (1997) (17)
- Impact on Life Expectancy of Withdrawing Thiopurines in Patients with Crohn’s Disease in Sustained Clinical Remission: A Lifetime Risk-Benefit Analysis (2016) (17)
- [Clinical tolerance, intestinal absorption, and energy value of four sugar alcohols taken on an empty stomach]. (1991) (17)
- Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy (2016) (17)
- Risk of serious infections with vedolizumab versus tumor necrosis factor antagonists in patients with inflammatory bowel disease. (2020) (17)
- 255 Aminosalicylates, Thiopurines and the Risk of Colorectal Cancer in Inflammatory Bowel Diseases: A Case-Control Study Nested in the CESAME Cohort (2010) (17)
- Push enteroscopy for gastrointestinal bleeding: diagnostic yield and long-term follow-up. (2004) (16)
- Appendicitis, not appendectomy, is protective against ulcerative colitis, both in the general population and first-degree relatives of patients with IBD. (2010) (16)
- Nancy Index Scores of Chronic Inflammatory Bowel Disease Activity Associate With Development of Colorectal Neoplasia. (2019) (16)
- Rotavirus-Like Particles: A Novel Nanocarrier for the Gut (2010) (16)
- Gastrointestinal bleeding diagnosed using video capsule endoscopy (2009) (15)
- Current smoking, not duration of remission, delays Crohn's disease relapse following azathioprine withdrawal. (2010) (15)
- Sorbitol absorption in the healthy human small intestine is increased by the concomitant ingestion of glucose or lipids. (1995) (14)
- Sera from patients with Crohn’s disease break bacterial lipopolysaccharide tolerance of human intestinal epithelial cells via MD-2 activity (2010) (14)
- Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility (2022) (13)
- Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis. (2020) (13)
- Intestinal perforation in Crohn's disease. Factors predictive of surgical resection. (2005) (13)
- [Prevalence and role of anticardiolipin antibodies in Crohn disease]. (1996) (13)
- Long‐term outcome of patients with acute severe ulcerative colitis responding to intravenous steroids (2020) (13)
- A Scoring System to Determine Patients' Risk of Colectomy Within 1 y After Hospital Admission for Acute Severe Ulcerative Colitis. (2020) (13)
- [Assigning the cause of diarrhea and enterocolitis to drugs. Current approach and outlook for improvement]. (1998) (13)
- Epithelial apoptosis as a very early marker of drug-induced colitis: the example of ranitidine. (1996) (13)
- Inhibitory Effect of Ursodeoxycholic Acid on Clostridium difficile Germination Is Insufficient to Prevent Colitis: A Study in Hamsters and Humans (2018) (11)
- Irritable bowel syndrome is more frequent in patients hospitalized for ischaemic colitis: results of a case–control study (2009) (11)
- COVID-19 and IBD drugs: should we change anything at the moment? (2020) (11)
- Testing for course patterns in Crohn's disease using clustering analysis. (1989) (11)
- Extra-intestinal malignancies in inflammatory bowel diseases: An update with emphasis on MDCT and MR imaging features. (2015) (11)
- Results of culture form colonoscopically obtained specimens for bacteria and fungi in HIV-infected patients with diarrhea. (1996) (11)
- [Effects of preoperative artificial nutrition in intestinal resections for Crohn disease]. (1996) (10)
- [Natural history of Crohn disease]. (1993) (10)
- Crohn's disease patients' and gastroenterologists' perspectives towards de-escalating inflammatory bowel disease therapy. (2019) (10)
- Glucose does not facilitate the absorption of sorbitol perfused in situ in the human small intestine. (1997) (10)
- Differences in epidemiological features between ulcerative colitis and Crohn's disease: The early life-programmed versus late dysbiosis hypothesis. (2018) (10)
- [Intercurrent Klebsiella oxytoca colitis in a patient with Crohn's disease]. (2002) (10)
- Acute cryptosporidiosis as a cause of sudden recurrence of digestive symptoms in patients with Crohn's disease. (2010) (10)
- Impact of HIV infection on the course of inflammatory bowel disease and drug safety profile: a multicenter GETAID study. (2020) (9)
- [HIV enteropathy]. (1993) (9)
- The outcome of Crohn's disease patients refractory to anti-TNF and either vedolizumab or ustekinumab. (2020) (9)
- 7 - Thiopurine therapy is associated with a three-fold decrease in the incidence of advanced colorectal neoplasia in IBD patients with longstanding extensive colitis: the CESAME prospective data (2009) (9)
- Intestinal histoplasmosis in AIDS patients: report of three cases observed in France and review of the literature. (1995) (8)
- Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer (2022) (8)
- Effect of glucose and lipids on intestinal absorption of sorbitol: role of gastric emptying (1996) (8)
- Patients with drug-induced microscopic colitis should not be included in controlled trials assessing the efficacy of anti-inflammatory drugs in microscopic colitis. (2009) (8)
- Azathioprine induction of tumors with microsatellite instability: Risk evaluation using a mouse model (2015) (8)
- Evolution of endoscopic lesions in steroid-refractory acute severe ulcerative colitis responding to infliximab or cyclosporine. (2020) (8)
- P817 Live-vaccines and lactation in newborn exposed in utero to anti-TNF: A multi-centre French experience in inflammatory bowel disease (2018) (8)
- [Glucose stimulates the absorption of sorbitol through the human jejunal mucosa]. (1989) (8)
- Sequencing of over 100,000 individuals identifies multiple genes and rare variants associated with Crohns disease susceptibility (2021) (8)
- S1095 Withdrawal of Immunosuppression in Inflammatory Bowel Disease Treated with Infliximab Maintenance Therapy (2009) (8)
- 555 What Is the Prognosis of Silent Crohn's Disease ? (2013) (7)
- Chronic use of non‐steroidal anti‐inflammatory drugs does not alter colonic mucosa of patients without diarrhoea (2001) (7)
- [Gastrointestinal complications related to NSAIDs]. (2004) (7)
- Liver dysfunction in patients with IBD under immunosuppressive treatment: do we need to fear? (2010) (7)
- [Diarrhea caused by antibiotic therapy]. (1996) (7)
- Cancers Complicating Inflammatory Bowel Disease. (2015) (7)
- Characteristics Of Lymphoma In Patients With Inflammatory Bowel Disease: A Systematic Review. (2020) (7)
- [Introduction of the evidence]. (2004) (6)
- Overall Incidence of Hepatosplenic T Cell Lymphoma in Patients With Inflammatory Bowel Disease on Thiopurines: A Meta-Analysis of Three Population Based Studies (2011) (6)
- [Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations (Spanish version)]. (2015) (6)
- 622 Risk of Subsequent Cancer Under Immunosuppressive Therapy in Patients With Inflammatory Bowel Disease and Prior Cancer: Data From the CESAME Prospective Observational Cohort (2012) (6)
- Cyclospora sp :Life Cycle Studies in Patient by Electron‐Microscopy (1996) (6)
- DOP032 Crohn’s disease patients’ perspectives towards de-escalating immunosuppressive therapy: a comparative French and American survey (2018) (6)
- [Lithiasis of the common bile duct in the aged subject treated with endoscopy (227 patients)]. (1988) (6)
- Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases (2022) (6)
- Adenocarcinoma complicating Crohn's disease of the duodenum. (2001) (6)
- [Acute infectious diarrhea in adults: epidemiology and management]. (2013) (6)
- 113 LINKAGE ANALYSES OF CHROMOSOME 6 LOCI INCLUDING HLA, IN FAMILIAL AGGREGATIONS OF CROHNʼS DISEASE (1994) (6)
- [Contribution of telemedicine applied to digestive cancer]. (1999) (6)
- P358 Risk of incident cancer in patients with inflammatory bowel disease starting anti-TNF therapy while having prior malignancy within past 5 years (GETAID survey) (2014) (6)
- The prevention and management of Crohn’s disease postoperative recurrence: results from the Y-ECCO/ClinCom 2019 Survey (2020) (5)
- Comparative risk of incident cancer in patients with Inflammatory Bowel Disease with prior non-digestive malignancy according to immunomodulator: a multicenter cohort study. (2022) (5)
- [Multifocal inflammatory leukoencephalopathy: a complication of chemotherapy by fluorouracil and levamisole]. (1994) (5)
- Correction: Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population (2019) (5)
- A New Meta-Analysis of Overall Risk of Lymphoma in Patients With Inflammatory Bowel Disease on Thiopurine Therapy; Inclusion of the Eneida Population Study From Spain, and Differences Between Referral Center Studies and Population Based Studies (2011) (5)
- Decreased severity of Crohn's disease (CD) after smoking cessation. Preliminary results of a prospective intervention study (2000) (5)
- Vedolizumab Clinical Decision Support Tool Predicts Efficacy of Vedolizumab But Not Ustekinumab in Refractory Crohn's Disease. (2021) (5)
- Sa1804 Quorum Sensing Driven by N-Acyl-Homoserine Lactone in Inflammatory Bowel Diseases Associated Dysbiosis (2013) (5)
- Prognosis of lymphoma in patients with known Inflammatory Bowel Disease: a French multicentre cohort study. (2020) (5)
- Roseolovirus DNA in the colonic mucosa of HIV-seropositive patients with diarrhea. (2003) (5)
- Chronic pouchitis and Crohn's disease of the pouch after ileal pouch-anal anastomosis: Incidence and risk factors. (2021) (4)
- Long-Term Outcome of Patients with Crohn's Disease that Responds to Azathioprine. (2012) (4)
- I-CARE, a European prospective cohort study assessing safety and effectiveness of biologics in inflammatory bowel disease. (2022) (4)
- Guidelines of the French Society for Digestive Endoscopy (SFED). Role of endoscopy in microscopic colitis. (2005) (4)
- Excess Intestinal Lymphoproliferative Disorders in IBD (2011) (4)
- Calibrating Real‐World Evidence Studies Against Randomized Trials: Treatment Effectiveness of Infliximab in Crohn’s Disease (2021) (4)
- Perspectives From Patients and Gastroenterologists on De-escalating Therapy for Crohn’s Disease (2021) (4)
- Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data: Infliximab with thiopurines compared to infliximab monotherapy. (2021) (4)
- Absorption of zidovudine in patients with diarrhoea (2004) (4)
- [Locked-in syndrome caused by thrombosis of the basilar trunk after spinal manipulation]. (1983) (4)
- What is the minimal length of residual small bowel (RSB) necessary to maintain autonomy via the oral route in the short bowel syndrome (SBS) (1993) (3)
- Autologous Cellular Therapy Open Label Phase I Study in Crohn's Disease With Type 1 Regulatory (Tr1) Lymphocytes (CATS1) (2011) (3)
- W1295 Azathioprine (Aza) is Associated With Less Histological Inflammation of the Colon in Clinically Inactive Ibd (2010) (3)
- Prospective randomized trial comparing small peptides v/s whole proteins in patients with a high jejunostomy (1990) (3)
- Author Correction: The mutational constraint spectrum quantified from variation in 141,456 humans (2021) (3)
- [Recommendations for clinical practice for the treatment of ulcerative colitis]. (2004) (3)
- [Colonic epithelial lymphocytosis associated with self-limited chronic Brainerd-type diarrhea]. (2000) (3)
- P.35 Malnutrition and nutritional support in Crohn's disease: a prospective evaluation (1997) (3)
- [Azathioprine, 6-mercaptopurine, and inflammatory diseases of the intestine]. (1990) (3)
- Real-world use of therapeutic drug monitoring of CT-P13 in patients with inflammatory bowel disease: A 12-month prospective observational cohort study. (2020) (3)
- 141 Pregnancy Outcome in Inflammatory Bowel Disease for Women Treated with Thiopurine: Cohort from the CESAME Study (2009) (3)
- Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (2023) (3)
- 341 Risk of Incident Cancer in Patients With Inflammatory Bowel Disease Starting Anti-TNF Therapy While Having Prior Malignancy Within Past 5 Years (2014) (3)
- Effects of vaccination, recent use of NSAIDs and antibiotics on Crohn's disease clinical activity. A prospective cohort study (2003) (3)
- Postoperative diagnostic revision for Crohn disease after subtotal colectomy for inflammatory bowel disease (2020) (3)
- The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort Study (2022) (3)
- Do immunosuppressants have any impact on the need for surgery in Crohn's disease? (2003) (2)
- 34 Is a Light Tobacco Consumption Deleterious in Crohn's Disease? (2008) (2)
- Body mass index and disease activity at treatment initiation: potential new predictors of response to azathioprine therapy in IBD. (2010) (2)
- P638 Impact of extra-intestinal cancer diagnosis and treament on inflammatory bowel disease outcome (2013) (2)
- Toward Further Understanding of Crohn’s Disease-Related Fatigue: The Role of Depression and Emotional Processing (2020) (2)
- P516 Efficacy of adalimumab in refractory ulcerative colitis in clinical practice (2013) (2)
- Rectocolite hémorragique: anastomose iléo-rectale ou iléo-anale ? (2000) (2)
- [Extracorporeal lithotripsy. Preliminary results in 5 patients with calculi of the common bile duct]. (1987) (2)
- No Excess Cancer Recurrence After Immunosuppressive Drugs in a Meta-analysis of Cohorts of Patients With Immune-mediated Diseases: A Mirage Related to Propensity Bias? (2017) (2)
- Sa1118 Withdrawing or Continuing Maintenance Treatment With Thiopurines in Patients With Crohn's Disease in Sustained Clinical Remission: A Lifetime Risk-Benefit Analysis (2015) (2)
- [The risk of extra-colonic extension in Crohn's colitis]. (1993) (2)
- [Natural history of intestinal lesions in inflammatory bowel disease]. (2014) (2)
- [Prognosis in pancolonic forms of hemorrhagic rectocolitis]. (1996) (2)
- [Care patterns and resumption of social and occupational activities after exeresis surgery in Crohn's disease. Study of 58 patients]. (1995) (2)
- [IBD and increased risk of cancer: what is the reality?]. (2014) (2)
- [Anasarca caused by exudative enteropathy due to digestive Kaposi's sarcoma]. (1989) (2)
- [Antibiotic-associated diarrhea]. (2008) (2)
- T1285 Usefulness of Co-Treatment With Immunomodulators in Inflammatory Bowel Disease Patients Treated With Infliximab Maintenance Therapy (2010) (2)
- Risk of Squamous and Basal Cell Carcinomas in Patients With Inflammatory Bowel Disorders Exposed to Thiopurines: The CESAME National Cohort Study (2011) (2)
- [Colonic involvement in ileal Crohn's disease]. (1998) (2)
- [Diagnostic and therapeutic management of diarrhea in human immunodeficiency virus infected patients]. (1995) (2)
- [Treatment of Crohn disease in adults]. (1994) (2)
- Resolution of Fungemia Due to Fusarium Species in a Patient with Acute Leukemia Treated with Caspofungin (2010) (2)
- [Epidemiology of Crohn disease in Public Assistance-Hospitals in Paris. Data of hospitalizations 1981-1992]. (1996) (2)
- Single Immunoglobulin Infusion Can Reverse Hemodynamic Failure Associated With Severe Clostridium difficile Colitis (2009) (2)
- Small Bowel Adenocarcinoma During Crohn's Disease: A Prospective Observational Cohort Study (2011) (2)
- Dysbiosis in Inflammatory Bowel Disease: A Link With Antimicrobial Peptides Secretion? (2011) (2)
- [The clinical activity of Crohn's disease in the Paris area is maximal in the spring]. (1995) (1)
- Effect of azathioprine or 6-mercaptopurine on perianal lesions of Crohn's disease (2000) (1)
- SIDA et tube digestif (1995) (1)
- S1100 When Can We Stop Azathioprine in Crohn's Disease Patients in Long-Term Remission? (2009) (1)
- [Treatment of extended ulcerative colitis (severe colitis excluded)]. (2004) (1)
- [What is inflammatory bowel disease?]. (2005) (1)
- Impact of thiopurines and tumour necrosis factor antagonists on primary sclerosing cholangitis outcomes in patients with inflammatory bowel disease (2022) (1)
- P071 Risk Factors Associated With Small Bowel Adenocarcinoma in Crohn's Disease: A Case-Control Study (2007) (1)
- P020 MAM, an anti-inflammatory protein derived from Faecalibacterium prausnitzii as a biomarker in Crohn’s disease? (2020) (1)
- Search for asymptomatic coeliac disease in patients with spongiform encephalopathy. (1999) (1)
- Impact of pregnancy on the activity of Crohn's disease (CD) (2003) (1)
- Effect of an isotonic oral rehydration solution enriched with glutamine on fluid and sodium absorption in the human small intestine (1994) (1)
- Author Correction: Landscape of multi-nucleotide variants in 125,748 human exomes and 15,708 genomes (2021) (1)
- [Mechanical lithotripsy of calculi of the common bile duct]. (1987) (1)
- 950 Factors Associated With Durable Response to Infliximab 5 Years and Beyond: A Multi Center International Cohort (2013) (1)
- Transcript expression-aware annotation improves rare variant interpretation (2020) (1)
- [Ulcerative colitis: ileorectal or ileoanal anastomosis?]. (2000) (1)
- P.53 Lack of compensatory hyperphagia in HIV-infectedpatients with malabsorption (1996) (1)
- Commentary: monitoring for myelosuppression in IBD (2013) (1)
- [Functional diarrheas are not, in most cases, minor clinical forms of lymphocytic or collagenous colitis]. (1996) (1)
- M1949 Are Small Bowel Adenocarcinoma (SBA) Complicating Crohn's Disease (CD) Associated With Dysplasia? (2010) (1)
- [Recurrent edema of the small intestine with ascites]. (1989) (1)
- Thiopurines and myeloid disorders: is more caution needed when treating inflammatory bowel disease patients? (2014) (1)
- [Is the risk of lymphoma increased by immunosuppressive therapy in patients with inflammatory bowel disease? The missing link for considering early immunosuppressants]. (2004) (1)
- [Are epidemiologically linked cancers risk antecedents for rectocolonic cancer?]. (1988) (1)
- W1624 Dysbiosis in Inflammatoy Bowel Disease Leads to Dysmetabolism of Bile Acids (2009) (1)
- Mo1815 A Simple Biomarker for IBD Associated Dysbiosis:The Ratio of Iso-LCA/LCA Indicates Alteration of Isomeration of Bile Acids in the Intestinal Lumen (2015) (1)
- [The Fitz-Hugh-Curtis syndrome. Apropos of an unusual hepatic ultrasonic aspect]. (1984) (1)
- Decreased risk of treatment failure with vedolizumab and thiopurines combined compared with vedolizumab monotherapy in Crohn’s disease (2022) (1)
- 305 Clinical Significance of Pseudopolyps for Patients With Inflammatory Bowel Disease (2019) (1)
- Falk Symposium Series (2009) (1)
- Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study (2022) (1)
- Sa1104 Efficacy of Adalimumab in Refractory Ulcerative Colitis in Clinical Practice (2013) (1)
- Su1147 Meta-Analysis of Overall Risk of Lymphoma in Patients With Inflammatory Bowel Disease on Thiopurine Therapy With Inclusion of European and North American Studies: Differences Between Referral Center Studies and Population Based Studies (2013) (1)
- Increased risk of permanent stoma in Crohn’s disease associated with hidradenitis suppurativa: a case‐control study (2020) (1)
- [Practical forms for the use of the main drugs in the treatment of ulcerative colitis]. (2004) (1)
- [Acute diarrhea in the adult]. (2010) (1)
- Intraoperative random biopsies of strictureplasty sites can detect early small-bowel adenocarcinoma in patients with Crohn's disease. (2021) (1)
- Cancer risk in immune-mediated inflammatory diseases (IMID) (2013) (1)
- Meta-analysis of the Incidence of Hepatosplenic T-cell Lymphoma in Inflammatory Bowel Disease: An Update: 1257 (2011) (1)
- The Risk of Rheumatoid Arthritis, Psoriasis, and Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease Exposed to Anti-TNF: A Nationwide Danish Cohort Study (2021) (1)
- DOP80 Effectiveness of ustekinumab and vedolizumab in patients with Crohn’s disease refractory to anti-tumour necrosis factor: A multi-centre comparative study (2020) (1)
- C-reactive protein values after surgery for inflammatory bowel disease: is it still a good marker for intra-abdominal complication? A retrospective cohort study of 347 procedures (2022) (0)
- Predictive factors of failure of intensive intravenous treatment in severe ulcerative colitis (1998) (0)
- Correction (2015) (0)
- [Medical attitude toward colonic diverticulosis]. (1991) (0)
- Sa1883 Long-Term Evolution of Crohn's Disease Patients Responders to Azathioprine (2012) (0)
- [Ulcerohemorrhagic rectocolitis and Sneddon-Wilkinson sub-corneal pustulosis?]. (1987) (0)
- THU0051 LOW-DOSE INTERLEUKIN-2 SELECTIVELY EXPAND AND ACTIVATE REGULATORY T CELLS ACROSS 13 AUTOIMMUNE DISEASES. (2020) (0)
- Addendum: The mutational constraint spectrum quantified from variation in 141,456 humans (2021) (0)
- Rectocolite hémorragique : du diagnostic au traitement (2014) (0)
- Dénutrition et infection à VIH (1995) (0)
- Prevalence of anti-TNF contraindications in Crohn's disease: A cross-sectional survey from the GETAID. (2022) (0)
- Landscape of multi-nucleotide variants in 125,748 human exomes and 15,708 genomes (2020) (0)
- P.34 Predictive factors of failure of intensive intravenoustreatment in severe ulcerative colitis (1998) (0)
- PERFUSE: a French non-interventional study of patients with inflammatory bowel disease receiving infliximab biosimilar SB2: a 12-month analysis (2023) (0)
- P692 Quorum sensing driven by N-acyl-homoserine lactone in inflammatory bowel diseases associated dysbiosis (2013) (0)
- The effect of LRRK2 loss-of-function variants in humans (2020) (0)
- OP003 Increased risk of acute arterial events in young patients with severely active inflammatory bowel disease: a nationwide French cohort study. (2017) (0)
- DOP10 Early intestinal resection in Crohn’s Disease is not associated with severe long-term disease course (2023) (0)
- Effect of indinavir upon body weight of malnourished HIV-infected patients (1998) (0)
- P350 Comparative risk of incident cancer in patients with Inflammatory Bowel Disease with prior non-digestive malignancy according to immunomodulator: a multicenter cohort study (2022) (0)
- Author Correction: Characterising the loss-of-function impact of 5’ untranslated region variants in 15,708 individuals (2021) (0)
- Meta-Analysis Of Overall Risk Of Lymphoma In Patients With Inflammatory Bowel Disease On Thiopurine Therapy With Inclusion Of New Nationwide Population Based Studies: Differences Between Referral Center Studies and Population Based Studies (2013) (0)
- [Symptomatic treatment of constipation]. (1997) (0)
- Digestion of carbohydrates and functional digestive disorders. (1990) (0)
- The mutational constraint spectrum quantified from variation in 141,456 humans (2020) (0)
- Tu1930 Cats-1 Study: Immunomonitoring and Clinical Results of Treg Cell Therapy for Crohn's Disease (2012) (0)
- [Acute diarrhea in the adult. Diagnostic orientation and management in emergency situations]. (2001) (0)
- Risk of acute arterial events associated with treatment of inflammatory bowel diseases: a nationwide Danish cohort study (2022) (0)
- Prognostic value of primary tumor sidedness in patients with non-metastatic IBD related CRC - Is it the exception to the rule? (2022) (0)
- T1238 Fecal Microbiota Alterations in Inflammatory Bowel Disease (IBD): Decrease of Faecalibacterium Prausnitzii But No Quantitative Variation of Escherichia coli (2008) (0)
- Push enteroscopy for gastrointestinal bleeding (2004) (0)
- E20 EBV and lymphoma in IBD (2010) (0)
- P116 What is the prognosis of silent Crohn's disease? (2013) (0)
- Etiology and Management of Toxic Megacolon With Human lmmunodeficiency Virus Infection in Patients (1994) (0)
- One year multiple injections of antigen specific T regulatory lymphocytes in refractory crohn’s disease patients, extension of CATS1 study (2013) (0)
- Don't miss drug-induced lymphocytic colitis. (2001) (0)
- Non-steroidal anti-inflammatory drugs (NSDAIDs) as a risk factor of acute diarrhea: An epidemiologic case-crossover study (2000) (0)
- [Microscopic colitis: nosological face-lift and research tracks]. (2008) (0)
- [New infectious colitis]. (2002) (0)
- P198 Most of the Lymphoproliferative Disorders (LPD) Occurring in IBD Patients Receiving Azathioprine Belong to the Spectrum of Immunodeficiency-Associated LPD (ID-LPD) and Involve Extranodal Sites (2008) (0)
- Testing for the links between the degree of wasting, the level of dietary intake, and the severity of diarrhea in HIV-infected patients with chronic diarrhea (1995) (0)
- Lymphoma in IBD: how big is the risk ? (2011) (0)
- The Safety of Thiopurines: New Data, New Decisions (2010) (0)
- Web table 4 (2014) (0)
- [Non-lithiasis cholangitis and cholecystitis in HIV infection]. (1993) (0)
- Author Correction: Evaluating drug targets through human loss-of-function genetic variation (2021) (0)
- Sa554 CHRONIC POUCHITIS AND CROHN'S DISEASE OF THE POUCH AFTER ILEAL POUCH-ANAL ANASTOMOSIS : INCIDENCE AND RISK FACTORS (2021) (0)
- AssociationofGeneticVariantsinNUDT15WithThiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease (2019) (0)
- Letter to the editor. (2021) (0)
- P023 CROHN'S DISEASE PRESENTATION IN PEDIATRIC PATIENTS (2009) (0)
- Author Correction: A structural variation reference for medical and population genetics (2021) (0)
- Effects of smoking and oral contraceptive use on the clinical course of Crohn's disease (1998) (0)
- Web table 5 (2014) (0)
- P296 CATS1 study: Immunomonitoring and clinical results of Treg cell therapy for Crohn's disease (2012) (0)
- Air mass pushing the liver. (2011) (0)
- Iconographies supplémentaires de l'article : Extra-intestinal malignancies in inflammatory bowel diseases: An update with emphasis on MDCT and MR imaging features (2015) (0)
- [Lamprene in ano-perineal lesions of Crohn's disease. A retrospective study]. (1993) (0)
- S1726 Circulating Levels of MD-2 Are Elevated in Patients with Inflammatory Bowel Disease: Relevance to Loss of Tolerance of the Intestinal Epithelium to Commensal Bacteria and to the Related Risk of Cancer Development (2009) (0)
- on Pathogenesis and Progress in Management of IBD XXIst European of (2003) (0)
- P199 Hidradenitis suppurativa associated with Crohn’s disease: An increased risk of permanent stoma (2018) (0)
- Incidence and risk factors of serious viral infections in inflammatory bowel disease (2016) (0)
- Author Correction: Transcript expression-aware annotation improves rare variant interpretation (2021) (0)
- W1272 Predictive Factors of Response to Infliximab in Inflammatory Bowel Diseases (2010) (0)
- Do Thiopurines Really Decrease the Risk of Colorectal Cancer in Ulcerative Colitis? The Light is Coming from Concept-based Subgroup Analyses. (2015) (0)
- Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study. (2022) (0)
- [Non-digestive complications of inflammatory bowel diseases]. (2014) (0)
- Risk of recurrent acute arterial events associated with thiopurines and anti-TNF in inflammatory bowel diseases. (2022) (0)
- Predictors of a 15-Year Non Severe Course in Crohn's Disease (2011) (0)
- Characterization of acute colitis in immunocompetent adults: A prospective series of 93 cases* (1998) (0)
- Su1392 Benefit of Infliximab Re-Introduction After Successive Failure of Infliximab and Adalimumab in Crohn's Disease (2014) (0)
- Antibiotic-associated diarrhea and Clostridlum difficlle in the community (2001) (0)
- P474 Efficacy and safety of anti-TNF and vedolizumab in liver transplant recipients with inflammatory bowel disease (IBD) (2018) (0)
- Su1226 Evolution of the LéMann Index During the Course of Crohn's Disease (2015) (0)
- 1120 Incidence and Risk Factors of Serious Viral Infections in Inflammatory Bowel Disease (2016) (0)
- T1175 Can Crohn's Disease Burn Out? (2008) (0)
- P443 Risk of incident Cancer in Patients with Inflammatory Bowel Disease with Prior Breast Cancer: a Multicentre Cohort Study (2023) (0)
- [Carbohydrate digestion and intestinal function disorders]. (1990) (0)
- O10 Association between IL23R, ATG16L1, IRGM and NOD2 Susceptibility Genes and Subphenotypes on a Large Cohort of IBD Patients (2009) (0)
- P482 Impact of cytomegalovirus reactivation treatment on inflammatory bowel disease flare (2013) (0)
- P115 Chronic pouchitis and Crohn’s disease of the pouch after ileal pouch-anal anastomosis: incidence and risk factors (2021) (0)
- [Endoscopy of chronic inflammatory intestinal diseases: importance for surveillance]. (1999) (0)
- Evaluating drug targets through human loss-of-function genetic variation (2020) (0)
- [Recommendations for clinical practice for the treatment of ulcerative colitis: general method]. (2004) (0)
- Autoévaluations de l'article : Mastocytose : manifestations digestives (2010) (0)
- Author Index / Subject Index (2013) (0)
- Mo1699 Recent Treatment With Nonsteroidal Anti-Inflammatory Drugs is an Independent Risk Factor for Clostridium difficile Infection in Patients Hospitalized for Active Inflammatory Bowel Disease (2012) (0)
- Iconography : Push enteroscopy for gastrointestinal bleeding (2008) (0)
- [Refractory proctitis]. (2007) (0)
- Azathioprine May Not be Associated With Development of Colorectal Tumors With Microsatellite Instability in Patients With Inflammatory Bowel Disease (2016) (0)
- Mo1852 Impact of Fertility Treatment on Inflammatory Bowel Disease Outcomes (2016) (0)
- Iconography : Intestinal perforation in Crohn's disease (2008) (0)
- Risk of colorectal neoplasia according to histologic disease activity in patients with inflammatory bowel disease and colonic post-inflammatory polyps. (2023) (0)
- Body composition and mechanisms of weight gain in HIV-infected malnourished patients treated with indinavir (1998) (0)
- Mastocytose : manifestations digestives (2010) (0)
- Characterising the loss-of-function impact of 5’ untranslated region variants in 15,708 individuals (2020) (0)
- Digestive tolerance to carbohydrates in healthy subjects and in subjects with constipation, diseases of the colon and intolerance to foods. (1990) (0)
- A structural variation reference for medical and population genetics (2020) (0)
- Mo1267 Impact of Cytomegalovirus Reactivation Treatment on Inflammatory Bowel Disease Flare (2013) (0)
- Long-term safety of IBD drugs, Beaugerie L, (2012) (0)
- Klebsiella oxytoca as a potential agent of acute colitis (2000) (0)
- Small bowel adenocarcinoma (SBA) with and without Crohn disease (CD) (2003) (0)
- [Diagnostic discussion: chronic diarrhea in a Haitian]. (1986) (0)
- CESAME Substudy on Thiopurines in Pregnancy: Is This the Baby We Were Waiting For? (2011) (0)
- Sa1147 Course of Crohn's Disease (CD) in Thiopurine-Intolerant Patients (2015) (0)
- T1310 Almost One Half of Inflammatory Bowel Disease (IBD) Patients at High Risk of Colorectal Neoplasia Do Not Undergo Endoscopic Surveillance: A Clinical Practice Study Nested in the CESAME Cohort (2010) (0)
- A Meta-analysis of Risk of Lymphoma in IBD Patients: A Comparison between Patients Actively Using Thiopurines and Those with Past Use: 1842 (2013) (0)
- Chronic Diarrhea and Weight Loss in HIV-Infected Patients (1999) (0)
- P.73 ARE SMALL BOWEL ADENOCARCINOMA (SBA) COMPLICATING CROHN'S DISEASE (CD) ASSOCIATEDWITH DYSPLASIA? (2010) (0)
- A Meta-analysis of Age-specific Risk for Lymphoma with Immunomodulators for Inflammatory Bowel Disease: 1237 (2010) (0)
- Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study (2020) (0)
- Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Laurent Beaugerie?
Laurent Beaugerie is affiliated with the following schools:
